Hannah Brendan — SEC Form 4 filings
SEC reporting owner CIK 1929422. 7 Form 4 filings on record with FilingPulse; latest filed 2026-01-23.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-02 to 2026-01-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 1 filing — 38,924 shares, $24,166 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: purchase of 23,565 shares @ $0.63 ($14,846) in Quince Therapeutics, Inc., filed 2024-08-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | CBO, COO & CCO | 7 | 6 legs · 38,924 sh · $24,166 | — | 11 |
Form 4 filings — Hannah Brendan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-23 | 4 | Quince Therapeutics, Inc. (QNCX) | Grant/award (A): 365,000 (derivative) @ $0 | EDGAR |
| 2025-12-08 | 4 | Quince Therapeutics, Inc. (QNCX) | Option exercise (M): 2,271 @ $0.55 · Option exercise (M): 25,280 @ $0.94 · Option exercise (M): 2,271 (derivative) @ $0 · Option exercise (M): 25,280 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | Quince Therapeutics, Inc. (QNCX) | Grant/award (A): 37,736 @ $1.20 · Grant/award (A): 37,736 (derivative) @ $0.12 | EDGAR |
| 2025-02-11 | 4 | Quince Therapeutics, Inc. (QNCX) | Grant/award (A): 450,000 (derivative) @ $0 | EDGAR |
| 2024-08-21 | 4 | Quince Therapeutics, Inc. (QNCX) | Purchase (P): 2,155 @ $0.58 · Purchase (P): 2,500 @ $0.61 · Purchase (P): 3,424 @ $0.60 · Purchase (P): 2,280 @ $0.61 · Purchase (P): 5,000 @ $0.62 · Purchase (P): 23,565 @ $0.63 | EDGAR |
| 2024-06-05 | 4 | Quince Therapeutics, Inc. (QNCX) | Option exercise (M): 56,061 @ $0.55 · Option exercise (M): 56,061 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Quince Therapeutics, Inc. (QNCX) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1929422 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →